Clinical Trial

Efficacy and Safety Study of Tunodafil Hydrochloride Tablets in Erectile Dysfunction

Completed Phase 3
View on ClinicalTrials.gov →
Summary
This is a multicenter, randomized, double blind, placebo-controlled, parallel design study to evaluate the efficacy and safety of Tunodafil Hydrochloride Tablets in men with erectile dysfunction.
Trial Details
NCT Number NCT07692867
Lead Sponsor Yangtze River Pharmaceutical Group Co., Ltd.
Conditions Erectile Dysfunction
Enrollment 780 participants
Start Date 2021-04-01
Primary Completion 2021-11-23 (estimated)
Study Completion 2022-01-25 (estimated)
Updated on ClinicalTrials.gov 2026-07-09